Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) EBT Margin: 2017-2025

Historic EBT Margin for Assembly Biosciences (ASMB) over the last 6 years, with Sep 2025 value amounting to -85.23%.

  • Assembly Biosciences' EBT Margin rose 5520.00% to -85.23% in Q3 2025 from the same period last year, while for Sep 2025 it was -100.14%, marking a year-over-year increase of 3647.00%. This contributed to the annual value of -139.72% for FY2024, which is 71460.00% up from last year.
  • As of Q3 2025, Assembly Biosciences' EBT Margin stood at -85.23%, which was up 6.95% from -91.61% recorded in Q2 2025.
  • Assembly Biosciences' 5-year EBT Margin high stood at -85.23% for Q3 2025, and its period low was -300.66% during Q3 2021.
  • Moreover, its 3-year median value for EBT Margin was -123.41% (2024), whereas its average is -121.03%.
  • In the last 5 years, Assembly Biosciences' EBT Margin crashed by 29,098bps in 2021 and then soared by 6,329bps in 2025.
  • Over the past 4 years, Assembly Biosciences' EBT Margin (Quarterly) stood at -300.66% in 2021, then reached -152.58% in 2023, then soared by 1,106bps to -141.51% in 2024, then spiked by 5,520bps to -85.23% in 2025.
  • Its last three reported values are -85.23% in Q3 2025, -91.61% for Q2 2025, and -93.62% during Q1 2025.